Influenza Will Not Miss Opportunities
Open Access
- 15 December 2006
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 43 (12) , 1562-1564
- https://doi.org/10.1086/508781
Abstract
In healthy individuals, influenza causes self-limited disease. An appropriate immune response leads to a rapid viral clearance, thereby limiting the duration of viral shedding to <10 days in most adults. In contrast, subjects with an impaired immune response might not efficiently clear influenza infection, thereby leading to additional replication cycles and higher viral loads. In these circumstances, given the intrinsic abilities of this RNA virus to accumulate point mutations, the likelihood of the emergence of new quasi species increases rapidly. According to the resulting phenotypic changes, new emerging mutants can escape the different environmental constraints (antigenic drift), including the host's immune responses and drug pressures. At an individual level, such adapted viruses may contribute to viral persistence and decrease the efficacy of antiviral drugs. On a wider level, new drifted strains lead to vaccine escape and could promote progressive adaptation of animal strains to humans.Keywords
This publication has 17 references indexed in Scilit:
- Characterization of Multidrug-Resistant Influenza A/H3N2 Viruses Shed during 1 Year by an Immunocompromised ChildClinical Infectious Diseases, 2006
- Distribution of Amantadine‐Resistant H5N1 Avian Influenza Variants in AsiaThe Journal of Infectious Diseases, 2006
- Recovery of Drug‐Resistant Influenza Virus from Immunocompromised Patients: A Case SeriesThe Journal of Infectious Diseases, 2006
- Adamantane Resistance Among Influenza A Viruses Isolated Early During the 2005-2006 Influenza Season in the United StatesJAMA, 2006
- Oseltamivir Resistance during Treatment of Influenza A (H5N1) InfectionNew England Journal of Medicine, 2005
- Neuraminidase Inhibitor Susceptibility Network Position Statement: Antiviral Resistance in Influenza A/H5N1 VirusesAntiviral Therapy, 2005
- Neuraminidase Inhibitors for InfluenzaNew England Journal of Medicine, 2005
- Lower Respiratory Viral IllnessesAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Influenza Viruses Resistant to the Antiviral Drug Oseltamivir: Transmission Studies in FerretsThe Journal of Infectious Diseases, 2004
- Influenza Infections after Hematopoietic Stem Cell Transplantation: Risk Factors, Mortality, and the Effect of Antiviral TherapyClinical Infectious Diseases, 2004